Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial

Eugene S. Chung, Milton Packer, Kim Hung Lo, Adedigbo A. Fasanmade, James T. Willerson

Clinical Sciences

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial

Fingerprint

Medicine & Life Sciences